Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Fibrotic response in fibroblasts from congenital disorders of glycosylation.

Lecca MR, Maag C, Berger EG, Hennet T.

J Cell Mol Med. 2011 Aug;15(8):1788-96. doi: 10.1111/j.1582-4934.2010.01187.x.

2.

Dissection of a novel molecular determinant mediating Golgi to trans-Golgi network transition.

Schaub BE, Berger EG, Rohrer J.

Cell Mol Life Sci. 2008 Nov;65(22):3677-87. doi: 10.1007/s00018-008-8446-y.

PMID:
18953688
3.

Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated.

Schaub BE, Berger B, Berger EG, Rohrer J.

Mol Biol Cell. 2006 Dec;17(12):5153-62. Epub 2006 Oct 4.

4.

Genome-wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type-I patients.

Lecca MR, Wagner U, Patrignani A, Berger EG, Hennet T.

FASEB J. 2005 Feb;19(2):240-2. Epub 2004 Nov 15.

PMID:
15545299
5.

Golgi enzymes are enriched in perforated zones of golgi cisternae but are depleted in COPI vesicles.

Kweon HS, Beznoussenko GV, Micaroni M, Polishchuk RS, Trucco A, Martella O, Di Giandomenico D, Marra P, Fusella A, Di Pentima A, Berger EG, Geerts WJ, Koster AJ, Burger KN, Luini A, Mironov AA.

Mol Biol Cell. 2004 Oct;15(10):4710-24. Epub 2004 Jul 28.

6.

Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.

Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T.

Am J Hum Genet. 2004 Jul;75(1):146-50. Epub 2004 May 17.

7.

Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.

Grubenmann CE, Frank CG, Hülsmeier AJ, Schollen E, Matthijs G, Mayatepek E, Berger EG, Aebi M, Hennet T.

Hum Mol Genet. 2004 Mar 1;13(5):535-42. Epub 2004 Jan 6.

8.

Galactosyltransferase--still up and running.

Berger EG, Rohrer J.

Biochimie. 2003 Mar-Apr;85(3-4):261-74. Review.

PMID:
12770765
9.

ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg.

Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T.

Hum Mol Genet. 2002 Sep 15;11(19):2331-9.

PMID:
12217961
10.

Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId.

Hansske B, Thiel C, Lübke T, Hasilik M, Höning S, Peters V, Heidemann PH, Hoffmann GF, Berger EG, von Figura K, Körner C.

J Clin Invest. 2002 Mar;109(6):725-33.

11.

Ectopic localizations of Golgi glycosyltransferases.

Berger EG.

Glycobiology. 2002 Feb;12(2):29R-36R. Review.

PMID:
11886838
12.

Functional assignment of motifs conserved in beta 1,3-glycosyltransferases.

Malissard M, Dinter A, Berger EG, Hennet T.

Eur J Biochem. 2002 Jan;269(1):233-9.

13.

Small cargo proteins and large aggregates can traverse the Golgi by a common mechanism without leaving the lumen of cisternae.

Mironov AA, Beznoussenko GV, Nicoziani P, Martella O, Trucco A, Kweon HS, Di Giandomenico D, Polishchuk RS, Fusella A, Lupetti P, Berger EG, Geerts WJ, Koster AJ, Burger KN, Luini A.

J Cell Biol. 2001 Dec 24;155(7):1225-38. Epub 2001 Dec 24.

14.

MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If.

Schenk B, Imbach T, Frank CG, Grubenmann CE, Raymond GV, Hurvitz H, Korn-Lubetzki I, Revel-Vik S, Raas-Rotschild A, Luder AS, Jaeken J, Berger EG, Matthijs G, Hennet T, Aebi M.

J Clin Invest. 2001 Dec;108(11):1687-95. Erratum in: J Clin Invest. 2003 Mar;111(6):925.

15.

Tumor cells as the origin of elevated serum alpha1,3fucosyltransferase in association with malignancy.

Asao T, Kuwano H, Nakamura J, Okamura A, Berger EG, Matta KL, Yazawa S.

Clin Exp Metastasis. 2000;18(7):605-10.

PMID:
11688966
16.

Immobilisation on polystyrene of diazirine derivatives of mono- and disaccharides: biological activities of modified surfaces.

Chevolot Y, Martins J, Milosevic N, Léonard D, Zeng S, Malissard M, Berger EG, Maier P, Mathieu HJ, Crout DH, Sigrist H.

Bioorg Med Chem. 2001 Nov;9(11):2943-53.

PMID:
11597476
17.

Chemo-enzymatic synthesis of the Galili epitope Gal(alpha)(1-->3)Galbeta(1-->4)GlcNAc on a homogeneously soluble PEG polymer by a multi-enzyme system.

Brinkmann N, Malissard M, Ramuz M, Römer U, Schumacher T, Berger EG, Elling L, Wandrey C, Liese A.

Bioorg Med Chem Lett. 2001 Sep 17;11(18):2503-6.

PMID:
11549456
19.

Colocalization of beta 1,4galactosyltransferase with mannose 6-phosphate receptor in monensin-induced TGN-derived structures.

Berger EG, Berger B, Höchli M, Dinter A.

Histochem Cell Biol. 2001 Feb;115(2):157-68.

PMID:
11444150
20.

Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase.

Legaigneur P, Breton C, El Battari A, Guillemot JC, Auge C, Malissard M, Berger EG, Ronin C.

J Biol Chem. 2001 Jun 15;276(24):21608-17. Epub 2001 Feb 20.

21.

Phorbol ester treatment of HL 60 leukemia cells results in increase of beta-(1 --> 4)-galactosyltransferase.

Pasqualetto V, Lemaire S, Neel D, Aubery M, Berger EG, Derappe C.

Carbohydr Res. 2000 Sep 22;328(3):301-5.

PMID:
11072837
22.

Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS.

Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, Hennet T, Imbach T, Stutz A, Bjursell C, Uller A, Wahlström JG, Briones P, Cardo E, Clayton P, Winchester B, Cormier-Dalre V, de Lonlay P, Cuer M, Dupré T, Seta N, de Koning T, Dorland L, de Loos F, Kupers L, et al.

Glycoconj J. 1999 Nov;16(11):669-71. No abstract available.

PMID:
11003549
23.

A solid-phase glycosyltransferase assay for high-throughput screening in drug discovery research.

Donovan RS, Datti A, Baek MG, Wu Q, Sas IJ, Korczak B, Berger EG, Roy R, Dennis JW.

Glycoconj J. 1999 Oct;16(10):607-15.

PMID:
10972139
24.

Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic.

Imbach T, Grünewald S, Schenk B, Burda P, Schollen E, Wevers RA, Jaeken J, de Klerk JB, Berger EG, Matthijs G, Aebi M, Hennet T.

Hum Genet. 2000 May;106(5):538-45.

PMID:
10914684
25.

Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells.

Schnyder-Candrian S, Borsig L, Moser R, Berger EG.

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8369-74.

27.

The beta 1,3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase.

Zhou D, Henion TR, Jungalwala FB, Berger EG, Hennet T.

J Biol Chem. 2000 Jul 28;275(30):22631-4.

28.

Complete enzymic synthesis of the mucin-type sialyl Lewis x epitope, involved in the interaction between PSGL-1 and P-selectin.

Zeng S, Gallego RG, Dinter A, Malissard M, Kamerling JP, Vliegenthart JF, Berger EG.

Glycoconj J. 1999 Sep;16(9):487-97.

PMID:
10815985
29.

Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.

Imbach T, Schenk B, Schollen E, Burda P, Stutz A, Grunewald S, Bailie NM, King MD, Jaeken J, Matthijs G, Berger EG, Aebi M, Hennet T.

J Clin Invest. 2000 Jan;105(2):233-9.

30.
32.

UDP-N-Acetyl-alpha-D-glucosamine as acceptor substrate of beta-1,4-galactosyltransferase. Enzymatic synthesis of UDP-N-acetyllactosamine.

Elling L, Zervosen A, Gallego RG, Nieder V, Malissard M, Berger EG, Vliegenthart JF, Kamerling JP.

Glycoconj J. 1999 Jul;16(7):327-36.

PMID:
10619705
33.

The yeast expression system for recombinant glycosyltransferases.

Malissard M, Zeng S, Berger EG.

Glycoconj J. 1999 Feb;16(2):125-39. Review.

PMID:
10612412
34.

Tn-syndrome.

Berger EG.

Biochim Biophys Acta. 1999 Oct 8;1455(2-3):255-68. Review.

37.

B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis.

Keusch J, Lydyard PM, Berger EG, Delves PJ.

Glycoconj J. 1998 Nov;15(11):1093-7.

PMID:
10386894
38.

A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic.

Imbach T, Burda P, Kuhnert P, Wevers RA, Aebi M, Berger EG, Hennet T.

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6982-7.

39.

A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1,3-galactosyltransferases.

Zhou D, Dinter A, Gutiérrez Gallego R, Kamerling JP, Vliegenthart JF, Berger EG, Hennet T.

Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):406-11.

40.

In situ generated O-glycan core 1 structure as substrate for Gal(beta 1-3)GalNAc beta-1,6-GlcNAc transferase.

Dudziak G, Zeng S, Berger EG, Gallego RG, Kamerling JP, Kragl U, Wandrey C.

Bioorg Med Chem Lett. 1998 Sep 22;8(18):2595-8.

PMID:
9873587
41.

Antibody recognition of epitopes on wild-type and mutant beta-(1-->4)-galactosyltransferase-1.

Keusch J, Panayotou G, Malissard M, Berger EG, Appert HE, Lydyard PM, Delves PJ.

Carbohydr Res. 1998 Nov;313(1):37-48.

PMID:
9861700
42.

A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.

Burda P, Borsig L, de Rijk-van Andel J, Wevers R, Jaeken J, Carchon H, Berger EG, Aebi M.

J Clin Invest. 1998 Aug 15;102(4):647-52.

43.

Golgi-disturbing agents.

Dinter A, Berger EG.

Histochem Cell Biol. 1998 May-Jun;109(5-6):571-90. Review.

PMID:
9681636
44.

Trafficking and localization studies of recombinant alpha1, 3-fucosyltransferase VI stably expressed in CHO cells.

Borsig L, Katopodis AG, Bowen BR, Berger EG.

Glycobiology. 1998 Mar;8(3):259-68.

PMID:
9451035
45.
46.

T lymphocyte activation results in an increased expression of beta-1,4-galactosyltransferase: phorbol ester induces a similar enhancement in the absence of mitosis.

Lemaire S, Derappe C, Pasqualetto V, Mrkoci K, Berger EG, Aubéry M, Néel D.

Glycoconj J. 1998 Feb;15(2):161-8.

PMID:
9557876
47.

Repressed beta-1,3-galactosyltransferase in the Tn syndrome.

Felner KM, Dinter A, Cartron JP, Berger EG.

Biochim Biophys Acta. 1998 Feb 27;1406(1):115-25.

48.

Immunodetection of glycosyltransferases: prospects and pitfalls.

Berger EG, Burger P, Borsig L, Malissard M, Felner KM, Zeng S, Dinter A.

Adv Exp Med Biol. 1998;435:119-32. Review. No abstract available.

PMID:
9498071
49.

Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus.

Röttger S, White J, Wandall HH, Olivo JC, Stark A, Bennett EP, Whitehouse C, Berger EG, Clausen H, Nilsson T.

J Cell Sci. 1998 Jan;111 ( Pt 1):45-60.

50.

Genomic cloning and expression of three murine UDP-galactose: beta-N-acetylglucosamine beta1,3-galactosyltransferase genes.

Hennet T, Dinter A, Kuhnert P, Mattu TS, Rudd PM, Berger EG.

J Biol Chem. 1998 Jan 2;273(1):58-65.

Supplemental Content

Loading ...
Support Center